Compare TTK HEALTHCARE with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PROCTER & GAMBLE HEALTH TTK HEALTHCARE/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 17.1 52.2 32.7% View Chart
P/BV x 1.4 4.7 28.9% View Chart
Dividend Yield % 1.1 10.0 11.3%  

Financials

 TTK HEALTHCARE   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
PROCTER & GAMBLE HEALTH
Dec-18
TTK HEALTHCARE/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,2153,549 34.2%   
Low Rs6101,301 46.9%   
Sales per share (Unadj.) Rs444.4511.4 86.9%  
Earnings per share (Unadj.) Rs17.261.3 28.1%  
Cash flow per share (Unadj.) Rs27.674.0 37.3%  
Dividends per share (Unadj.) Rs5.00440.00 1.1%  
Dividend yield (eoy) %0.518.1 3.0%  
Book value per share (Unadj.) Rs177.9927.8 19.2%  
Shares outstanding (eoy) m14.1316.60 85.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.7 43.3%   
Avg P/E ratio x52.939.6 133.7%  
P/CF ratio (eoy) x33.032.8 100.8%  
Price / Book Value ratio x5.12.6 196.2%  
Dividend payout %29.0717.9 4.0%   
Avg Mkt Cap Rs m12,89440,257 32.0%   
No. of employees `0002.31.1 203.9%   
Total wages/salary Rs m1,3071,313 99.6%   
Avg. sales/employee Rs Th2,715.77,486.7 36.3%   
Avg. wages/employee Rs Th565.31,157.6 48.8%   
Avg. net profit/employee Rs Th105.4897.2 11.7%   
INCOME DATA
Net Sales Rs m6,2798,490 74.0%  
Other income Rs m78244 31.8%   
Total revenues Rs m6,3568,734 72.8%   
Gross profit Rs m4961,482 33.5%  
Depreciation Rs m147211 69.5%   
Interest Rs m340-   
Profit before tax Rs m3931,514 25.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m149563 26.5%   
Profit after tax Rs m2441,017 24.0%  
Gross profit margin %7.917.5 45.2%  
Effective tax rate %37.937.1 102.1%   
Net profit margin %3.912.0 32.4%  
BALANCE SHEET DATA
Current assets Rs m2,71715,343 17.7%   
Current liabilities Rs m1,5711,960 80.1%   
Net working cap to sales %18.3157.6 11.6%  
Current ratio x1.77.8 22.1%  
Inventory Days Days3249 66.0%  
Debtors Days Days4728 164.0%  
Net fixed assets Rs m9911,209 81.9%   
Share capital Rs m141166 85.1%   
"Free" reserves Rs m2,37315,235 15.6%   
Net worth Rs m2,51415,401 16.3%   
Long term debt Rs m30-   
Total assets Rs m4,15817,595 23.6%  
Interest coverage x12.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.50.5 312.9%   
Return on assets %6.75.8 115.4%  
Return on equity %9.76.6 146.7%  
Return on capital %16.910.3 165.1%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m2251,636 13.8%   
Fx outflow Rs m714,368 1.6%   
Net fx Rs m154-2,732 -5.6%   
CASH FLOW
From Operations Rs m173-1,304 -13.3%  
From Investments Rs m9712,697 0.8%  
From Financial Activity Rs m-307-301 102.3%  
Net Cashflow Rs m-3811,093 -0.3%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.7 18.2 20.3%  
FIIs % 5.2 1.0 520.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 29.1 88.7%  
Shareholders   12,723 28,591 44.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  WOCKHARDT  SUN PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum, Key Q2FY20 Results, and Top Cues in Focus Today(Pre-Open)

On Wednesday, Indian share markets traded on a volatile note throughout the day and ended marginally higher.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Oct 16, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS